Skip to main content
. 2019 Nov 22;62(2):79–90. doi: 10.1007/s12033-019-00222-1

Table 1.

Developmental status of edible vaccines in clinical trials

Pathogen Antigen Host Use Clinical trial status References

Enterotoxigenic

E. coli

LT- B Potato Diarrhoea Early phase 1 [104]

Enterotoxigenic

E. coli

LT- B Maize Diarrhoea Early phase 1 [105]
Norwalk Virus CP Potato Diarrhoea Early phase 1 [106]
Rabies Virus GP/ NP Spinach Rabies Early phase 1 [107]
HBV HBsAg Lettuce Hepatitis B Early phase 1 [108]
HBV HBsAg Potato Hepatitis B Phase 1 [109]
Vibrio cholerae CTB Rice Cholera Phase 1 [110, 111]
HBV HBV

Saccharomyces

cerevisiae

Chronic HBV Phase 2 [112]
HCV HCV

Saccharomyces

Cerevisiae

Chronic HCV Phase 2 [113]